Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 17, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019
Market Capitalization	1,065,113	921,654	-	-	-	-	Upgrade
Enterprise Value	1,024,911	902,241	-	-	-	-	Upgrade
Last Close Price	2581.60	2300.75	-	-	-	-	Upgrade
PE Ratio	50.81	48.18	-	-	-	-	Upgrade
Forward PE	48.32	43.88	-	-	-	-	Upgrade
PS Ratio	9.15	8.92	-	-	-	-	Upgrade
PB Ratio	9.87	9.63	-	-	-	-	Upgrade
P/TBV Ratio	11.93	12.00	-	-	-	-	Upgrade
P/FCF Ratio	-	50.17	-	-	-	-	Upgrade
P/OCF Ratio	-	42.82	-	-	-	-	Upgrade
PEG Ratio	2.72	1.91	-	-	-	-	Upgrade
EV/Sales Ratio	8.80	8.73	-	-	-	-	Upgrade
EV/EBITDA Ratio	35.22	35.57	-	-	-	-	Upgrade
EV/EBIT Ratio	41.50	41.93	-	-	-	-	Upgrade
EV/FCF Ratio	-	49.11	-	-	-	-	Upgrade
Debt / Equity Ratio	0.05	0.02	0.02	0.14	0.06	0.04	Upgrade
Debt / EBITDA Ratio	0.17	0.08	0.09	0.44	0.16	0.09	Upgrade
Debt / FCF Ratio	-	0.11	0.17	1.94	0.34	0.16	Upgrade
Asset Turnover	-	0.95	0.93	1.00	1.09	1.28	Upgrade
Inventory Turnover	-	2.18	1.84	1.69	1.77	2.24	Upgrade
Quick Ratio	-	2.02	1.14	0.65	1.78	1.33	Upgrade
Current Ratio	-	3.10	2.32	1.68	2.89	2.26	Upgrade
Return on Equity (ROE)	-	22.58%	18.79%	25.99%	30.30%	31.75%	Upgrade
Return on Assets (ROA)	-	12.41%	10.53%	14.76%	17.37%	20.01%	Upgrade
Return on Capital (ROIC)	15.29%	15.30%	13.24%	18.56%	22.22%	26.05%	Upgrade
Return on Capital Employed (ROCE)	-	21.90%	20.20%	28.10%	31.70%	38.50%	Upgrade
Earnings Yield	191.66%	2.08%	-	-	-	-	Upgrade
FCF Yield	-	1.99%	-	-	-	-	Upgrade
Payout Ratio	-	-	-	-	-	29.35%	Upgrade
Buyback Yield / Dilution	-19.70%	-0.14%	-0.00%	-	-	-	Upgrade
Total Shareholder Return	-19.70%	-0.14%	-0.00%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.